Eli Lilly Chief AI Officer Thomas Fuchs on AI's Power to Transform Pharma
Podcasts
•
21m
AI is revolutionizing pharmaceuticals, moving from a side tool to a core driver of many aspects of the industry. Eli Lilly is leading the way, appointing Thomas Fuchs as its first Chief AI Officer to integrate AI across its pipeline. A NASA and Mount Sinai veteran, Fuchs is turning Lilly’s data into a competitive edge. He joins Inside the ICE House to share how Lilly is building the AI-powered medicine company of the future.
Up Next in Podcasts
-
ETF Central: Parametric Managing Dire...
Alex Zweber, Portfolio Manager and Strategist at Parametric under Morgan Stanley Investment Management, joins Bilal Little, Director of Exchange Traded Products at the NYSE, to share his journey from derivatives trading to leading Parametrics' liquid alternatives team. He discusses the explosive ...
-
8-29-2025: Word of the Week... Indepe...
Michael Reinking, Senior Market Strategist for the NYSE, recaps a busy week following Fed Chair Powell’s dovish Jackson Hole remarks, which fueled a market rally and left the door open for a September rate cut. He highlights political drama around Fed independence, the U.S. taking stakes in Intel...
-
AI, Ambition, and Innovation with Hum...
Artificial intelligence is reshaping industries by unlocking insights hidden within massive amounts of unstructured data. With powerful tools like vector databases and enterprise platforms, AI is driving breakthroughs across healthcare, finance, and entertainment. Pinecone founder Edo Liberty and...
